| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.006 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |